Article

New York Post on 2020-04-08 13:59

Novavax to start human trial for ‘ideal’ coronavirus vaccine candidate

The biotech company Novavax announced Wednesday that it has identified an "ideal" coronavirus vaccine candidate.

Related news

Novavax begins human testing of coronavirus vaccine candidate bizjournals.com
Novavax begins phase 3 trial of flu vaccine candidate thedailyrecord.com
As coronavirus pandemic continues, Novavax starts clinical trial of potential vaccine in Australia Fox News
Arecibo , Australia , Maryland , Melbourne , Australia
MNovavax starting trial of COVID-19 vaccine in South Africa marketwatch.com
South Africa
Novavax to test its Covid vaccine candidate in another UK trial bizjournals.com
Novavax says Covid-19 vaccine shows 90.4% overall efficacy in US/Mexico Phase 3 trial CNN
United Kingdom , United States , Mexico
CNovavax: Early study indicates its vaccine effective vs. RSV contracostatimes.com
Maryland , Gaithersburg
Coronavirus vaccine: Novavax begins h...expressandstar.com
Australia , Phase 1 , Brisbane , Melbourne , Australia
Novavax awaits FDA ruling over new COVID vaccine bangordailynews.com
Australia , United Kingdom , Mexico , Asia , Europe
Novavax trials COVID-19 vaccine candidate in Australia post-gazette.com
Australia
MNovavax shares plummet more than 80% after vaccine trial fails marketwatch.com
FNovavax to complete US vaccine trial enrolment in record time ft.com
Novavax shares jump on positive news of flu vaccine trial bizjournals.com
Novavax kicks off 2019 with positive flu vaccine trial results bizjournals.com
MNovavax stock rises on funding for COVID-19 vaccine trial marketwatch.com
China , Wuhan
FCoronavirus latest: Novavax launches first phase 3 Covid vaccine trial ft.com
FNovavax vaccine trial shows 90% efficacy in combating Covid-19 ft.com